Biotech Investor Video Production | Research Triangle | K2 Productions
Biotech investor video production is the process of creating professional video content — company overviews, mechanism-of-action explainers, facility documentaries, and pipeline milestone videos — that helps life sciences companies in the Research Triangle communicate their science, team, and traction to investors, partners, and potential hires. K2 Productions has produced this work for biotech and life sciences companies across Raleigh, Durham, Chapel Hill, and RTP for 20 years.
Great science does not fund itself. In a Research Triangle now competing at a global scale, the companies attracting capital are the ones who learned to tell their story before they needed to — and who built the production infrastructure to tell it well at every stage.
K2 Productions is a full-service video production company with 20 years of experience producing company overview videos, mechanism of action content, facility and team documentary work, and AV production for life sciences companies across Raleigh, Durham, Chapel Hill, and RTP — including an active production partnership with ChromaGenix, whose new GMP chromatography facility K2 produced at ribbon-cutting in April 2026.
Why the RTP Biotech Market Demands Better Storytelling Now
Last month, K2 Productions was on-site for the grand opening of ChromaGenix’s new GMP chromatography facility — handling AV for the ceremony, filming the ribbon cutting, and continuing a production partnership that includes their company overview, b-roll library, and partnership video. ChromaGenix is the only advanced modality company focused on chromatography from discovery through commercialization, backed by $5M in investment and built on proprietary science from NC State.
The room that day was full of scientists, investors, and community leaders who believed completely in what was being built — not in a polished, rehearsed way, but in the way that happens when a team has spent years grinding toward something real. What that team understands, and what brought K2 into this partnership, is that the science alone does not carry the mission. The story of science does.
The Investment Standard Has Shifted in RTP — And So Has What Investors Expect
The Research Triangle has always had the science — Duke, UNC, NC State, a genuinely world-class academic pipeline — but what has changed in the last two years is the scale of capital and institutional attention the region is attracting, and with it, the standard investors apply to every company they evaluate here.
Biogen committed $1 billion to expand its RTP operations. Novo Nordisk put $1.1 billion into GLP-1 production in Clayton. Fujifilm opened one of the largest cell culture manufacturing facilities in North America in Holly Springs. When anchor companies of that scale are present in a region, national and international investors who might have overlooked Raleigh five years ago are now actively looking — and applying the same lens they use everywhere else.
The question is no longer whether a Triangle company is impressive relative to its geography. It is whether it is fundable by the standard applied everywhere, and increasingly, investors start answering that question before they ever agree to a first call.
How Biotech Investors Evaluate Your Company Before the First Call
Most biotech founders believe the investor conversation begins when they walk into a pitch. It began weeks earlier, when an analyst typed their company name into a search engine and opened their website. What was there — video, team page, science communication, or the absence of all three — formed the first impression that shapes whether the meeting happens at all.
Video communicates things that text and slide decks cannot: how your CEO thinks under no-script pressure, whether your team can translate molecular biology into a narrative a generalist investor can follow, and what kind of organization is behind the science. As AI-generated content floods biotech channels, human-led storytelling — real people, real conviction on camera — is increasingly how serious companies distinguish themselves.
That is exactly why the company overview, partnership video, and b-roll library K2 is building with ChromaGenix are designed to make the energy of that ribbon-cutting room visible to every investor, partner, and future hire who was not there.
What Types of Biotech Investor Video Actually Move Capital?
Not all video is equally valuable at every stage. Understanding which type serves which moment is what separates a coherent production strategy from a collection of one-off projects.
Founder / CEO Narrative
The story investors need at every stage: why this person, why this problem, why now. A skilled director creates the conditions for genuine conviction to surface — the right environment, the right questions, the space to stop performing and start talking — because what investors actually need to see is not a polished spokesperson but the person who cannot imagine doing anything else.
Mechanism of Action / Platform Explainer Video
The video that travels furthest within a firm, without you in the room, from analyst to partner to investment committee, without caveats or explanation from the company. Translating molecular complexity into something a smart generalist can follow in under two minutes is a real craft problem. A poorly executed MOA video — inaccurate, visually dated, or pitched at the wrong level — does more damage than having nothing at all.
Facility & Team Documentary
Abstract science is the hardest thing for an early investor to commit to. A facility and team video collapses the distance between a concept and a company by showing real people doing real work in a real place. Most Triangle biotechs have never put their physical infrastructure on camera, which makes it one of the most underused storytelling assets in the region.
Pipeline Milestone / Data Narrative Video
Built for a specific inflection point — a Phase I readout, a platform expansion, a major partnership announcement — and aimed at an audience that is expert and skeptical. The discipline here is transparency over celebration: be specific about what was proven, honest about what remains, and clear about what the inflection point means for the broader program, because that honesty is more persuasive than any amount of production value.
Life Sciences Video Production in Raleigh, Durham, and RTP: K2 Productions
Whether or not you have invested in telling your story, a story is already being told — by what investors find when they look for you, by the quality and clarity of whatever content you have, and by the gap between the science you are doing and the communication infrastructure you have built around it.
The ChromaGenix team understood something that the most successful companies in this region all seem to understand: the mission does not carry itself, and investing in how you communicate it is as fundamental as the science.
The companies that do this well do not commission a video and move on. They have a production partner who knows their science, their team, and their milestones well enough to capture the right moment at the right time — so that when a Phase I readout comes in, when a partnership is announced, when a new facility opens, the team already embedded can respond with the speed and context to tell the story correctly.
For 20 years, K2 Productions has helped companies across industries make complex, important work visible to the people who need to see it — through director-led storytelling, the ability to get unscripted conviction on camera, and the skill to translate technical depth into something a generalist can follow and feel. K2 Productions operates in 10 markets across the Southeast and Mid-Atlantic.
Work With K2 Productions
Questions worth asking before your next raise:
- Does your current video tell the story an investor needs to hear before you are in the room?
- Do you have a mechanism-of-action video that could survive being forwarded within an investment firm?
- Has your facility and team ever been on camera in a way that makes your mission feel real?
- Do you have a production partner who knows your science well enough to capture the right moment when it arrives?
K2 Productions is a director-led video production company with 20 years of experience serving life sciences, technology, and enterprise clients. The company operates across ten markets in the Southeast and Mid-Atlantic, with deep roots in the Research Triangle biotech ecosystem. K2 specializes in investor communications, mechanism-of-action animations, facility documentaries, and science storytelling for companies at every stage, from pre-seed to publicly traded.
Sources
Bioxconomy Roundtable, December 2025 — bioxconomy.com
Economic Development Partnership of North Carolina — nccommerce.com
NC Biotechnology Center — ncbiotech.org
CBRE 2025 U.S. Life Sciences Outlook — cbre.com
Hatteras Venture Partners — hatterasvp.com
PitchBook Life Sciences Data — pitchbook.com